Ajanta Pharma Limited (AJANTPHARM.NS) NSE
Currency In INR
- General
- Statistics
- Historical Data
- Profile
- Financials
Currency In INR
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
10421
First IPO Date
July 01, 2002
| Name | Title | Pay | Year Born |
| Madhusudan Bhagwandas Agrawal | Executive Vice Chairman of the Board | 52.8M | 1955 |
| Rajesh Mannalal Agrawal | Joint MD & Director | 275.28M | 1976 |
| Yogesh Mannalal Agrawal | MD & Executive Director | 275.28M | 1972 |
| Arvind K. Agrawal | Chief Financial Officer | 0 | 1963 |
| Gaurang C. Shah | Senior VP of Legal & Corporate Affairs, Company Secretary and Compliance & Nodal Officer | 0 | N/A |
| H. Nandkishore Agrawal | President of International Business | 0 | 1960 |
| H. Satish Agrawal | President of Technical & Operations | 0 | 1963 |
| Abhineet Kumar | Sr GM of Corporate Communication | 0 | N/A |
| Pourus Vakil | President of Sales & Marketing | 0 | N/A |
| Thampy Jacob | Senior Vice President of HR | 0 | N/A |
Established in 1973 and headquartered in Mumbai, India, Ajanta Pharma Limited operates as a specialized pharmaceutical enterprise. This company, along with its subsidiaries, is dedicated to the development, manufacturing, and commercialization of finished dosage forms. Its extensive product range caters to numerous therapeutic categories, such as anti-infectives (antibiotic, anti-malarial), chronic disease management (anti-diabetic, cardiology), women's health (gynecology), pediatrics, respiratory ailments, general health, dermatology, ophthalmology, and pain management. Notable products include multivitamins, antibiotics, eye drops, and cough syrups. Ajanta Pharma boasts a substantial international footprint, operating across India, Africa, other parts of Asia, the United States, and additional global markets. Furthermore, it supplies its pharmaceutical offerings to various government entities, including armed forces, public hospitals, and governmental procurement departments.